15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $28M | -$249M | 0.0% | 0.0% | — | $3.9B | $26M |
| 2024 | $19M | -$664M | 0.0% | 0.0% | — | $4.7B | $69M |
| 2023 | $17M | -$282M | 0.0% | 0.0% | — | $5.0B | $26M |
| 2022 | $14M | $41M | 0.0% | 0.0% | — | $5.4B | $61M |
| 2021 | $10M | $67M | 0.0% | 0.0% | $135M | $1.8B | $13M |
| 2020 | $7M | $72M | 0.0% | 0.0% | $395M | $3.0B | $115M |
| 2019 | — | $30M | — | — | $249M | $2.7B | $33M |
| 2018 | — | $213M | — | — | $260M | $2.5B | $126M |
| 2017 | — | $64M | — | — | $243M | $2.8B | $100M |
| 2016 | — | $46M | — | — | $161M | $1.8B | $11M |
| 2015 | — | $33M | — | — | $162M | $1.6B | $13M |
| 2014 | — | $45M | — | — | $139M | $1.4B | $10M |
| 2013 | — | $24M | — | — | $122M | $1.2B | $18M |
| 2012 | — | -$24M | — | — | $94M | $1.0B | $16M |
| 2011 | — | $6M | — | — | $96M | $639M | $69M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $8M | -$56000 | 0.0% | 0.0% | — | $4.1B | $26M |
| Dec '25 | $8M | $14M | 0.0% | 0.0% | — | $3.9B | $26M |
| Sep '25 | $7M | -$58M | 0.0% | 0.0% | — | $4.5B | $43M |
| Jun '25 | $7M | -$158M | 0.0% | 0.0% | — | $4.7B | $26M |
| Mar '25 | $6M | -$45M | 0.0% | 0.0% | — | $4.7B | $26M |
| Dec '24 | $6M | -$107M | 0.0% | 0.0% | — | $4.7B | $69M |
| Sep '24 | $5M | -$93M | 0.0% | 0.0% | — | $5.0B | $23M |
| Jun '24 | $4M | -$144M | 0.0% | 0.0% | — | $5.1B | $42M |
| Mar '24 | $4M | -$311M | 0.0% | 0.0% | — | $5.1B | $26M |
| Dec '23 | $4M | -$41M | 0.0% | 0.0% | — | $5.0B | $26M |
| Sep '23 | $5M | -$68M | 0.0% | 0.0% | $118M | $5.2B | $25M |
| Jun '23 | $4M | -$83M | 0.0% | 0.0% | — | $5.3B | $36M |
| Mar '23 | $5M | -$87M | 0.0% | 0.0% | — | $5.4B | $50M |
| Dec '22 | $4M | -$36M | 0.0% | 0.0% | — | $5.4B | $61M |
| Sep '22 | $4M | $28M | 0.0% | 0.0% | — | $5.6B | $58M |
| Jun '22 | $3M | $6M | 0.0% | 0.0% | — | $3.1B | $30M |
| Mar '22 | $2M | $42M | 0.0% | 0.0% | — | $3.1B | $11M |
| Dec '21 | $3M | $22M | 0.0% | 0.0% | — | $1.8B | $13M |
| Sep '21 | $3M | -$2M | 0.0% | 0.0% | — | $3.1B | $13M |
| Jun '21 | $2M | $23M | 0.0% | 0.0% | — | $3.1B | $20M |
How the market has priced HR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Healthcare Realty Trust Inc's revenue has grown 30.8% per year. These are computed facts, not advice.
As of FY2025, Healthcare Realty Trust Inc reported $3.9B of total debt against $26M of cash.
In FY2025, gross margin was —, operating margin —, and net margin -884.2%.
As of Jun '26, Healthcare Realty Trust Inc traded at a price-to-earnings ratio of about 146.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.